Developing efficient therapies for both acute and chronic wounds requires a thorough un-derstanding of wound healing mechanisms and possible therapeutic approaches. Preclinical research simulates wound healing processes and evaluates the effectiveness of novel medications and treat-ments using a range of experimental models. This review examines and contrasts the main preclinical models-in vitro, in vivo, in silico, explant, and genetically modified models that are employed in wound healing research. While in vivo models offer insights into complex tissue connections and systemic effects in animal subjects, in vitro models facilitate specific cellular and molecular studies to be conducted under controlled settings. The use of in silico models can reduce the requirement for animal testing by supporting predictive analysis and the computational simulation of wound healing processes. Explant models, which bridge the gap between cell cultures and whole-animal models, provide a more complicated environment than in vitro methods by using portions of tissue or organs. Furthermore, targeted research on gene-specific involvement in wound healing is enabled by genet-ically modified models, which are frequently based on animals with particular gene changes. These models' relative advantages and disadvantages are examined, emphasizing their applicability and complementary functions in experimental wound repair studies. This thorough analysis provides a cohesive perspective on each model's suitability, which aids in the development of preclinical ap-proaches for wound healing treatments.
Dubey et al. (Tue,) studied this question.